Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

HHS recommends first PI-sparing AIDS treatment regimen

Dec. 8, 1998

Canadian approval obtained for Serostim

Dec. 4, 1998

New HIV protease inhibitors in development at Monsanto

Dec. 3, 1998

Hydroxyurea-containing salvage regimens for advanced-stage HIV infection

Dec. 2, 1998

Clinical anti-HIV activity of FTC correlated with intracellular levels of triphosphate

Dec. 2, 1998

FDA informs Ligand that Panretin Gel is approvable

Dec. 1, 1998

First patient treated in phase II HIV gene therapy study

Dec. 1, 1998

More on the contraceptive effects, anti-HIV activity of WHI compounds

Nov. 27, 1998

Novel agents for HIV: protease inhibitor/reverse transcriptase inhibitor conjugates

Nov. 27, 1998

New treatment option for pediatric HIV/AIDS now available in U.S.

Nov. 27, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...